SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is surging as investors react to two major catalysts: the termination of a dilutive equity facility and the SEC's approval to remove pattern day trading restrictions, which is expected to drive significant user activity. The community is buzzing over the stock's potential for a multi-month recovery, with many comparing its current valuation to larger competitors and expressing bullish sentiment as the stock breaks through key resistance levels.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing massive volatility driven by a technical short squeeze and a supply-demand imbalance, as hedge funds and insiders control a significant majority of the float. The community is deeply divided, with bulls cheering the historic parabolic move toward triple digits while bears warn of an inevitable crash and express frustration over the stock's disconnect from its fundamental business value.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as investors digest the company's strong first-quarter earnings and revenue beat, coupled with a raised full-year earnings outlook that signals a successful shift toward margin-focused growth. Community discussion remains heavily divided between long-term holders celebrating a potential multi-year turnaround and bears skeptical of ongoing regulatory investigations and customer attrition, while traders are actively monitoring the stock for a broader breakout toward higher resistance levels.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group Inc. is experiencing intense volatility driven by news of an increased stake from strategic partner Uber, which has fueled speculation regarding the companys future in the robotaxi space. While some investors view the recent capital raises and expansion efforts as a foundational step toward commercialization, the community remains deeply divided, with many expressing frustration over persistent share dilution and the stock's proximity to all-time lows.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing a sharp rally and heightened market attention driven by a combination of a massive short squeeze, positive sentiment around the company's emerging peptide therapy initiatives, and strategic partnerships like the one with Novo Nordisk. Investors and traders are actively discussing the stock's potential for a sustained breakout, with the community closely tracking whether the momentum can overcome significant short interest as bulls target higher price levels.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc. is trending as investors rally around the companys strategic shift into the AI cloud and GPU infrastructure space, fueled by a high-profile share exchange deal with Northern Data and significant support from Tether. The community is actively discussing a potential short squeeze, citing elevated short interest and the anticipation of new catalyst milestones, leading many to hold for long-term growth while monitoring key price levels.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is currently trending due to intense speculation surrounding its electro-optic polymer technology, which investors are positioning as a critical enabler for high-speed AI data centers. The community is actively debating the company's transition from research-stage development to foundry-integrated production, with significant interest focused on its technical partnerships, upcoming conference presentations, and potential for major industry adoption.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense community focus as traders debate the potential for a short squeeze amid high short interest and a technical reversal setup. Investors are actively discussing the company's turnaround strategy, specifically highlighting positive signals in home acquisition volume and institutional positioning as catalysts that could drive a re-rating.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospace is capturing market attention as it nears all-time highs, with the community closely tracking its robust backlog and the potential for a significant earnings beat in upcoming reports. Investors are actively debating the sustainability of its current valuation against the company's strong industrial fundamentals and strategic role in global aerospace supply chains.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing massive volatility and institutional attention as the company aggressively expands its Bitcoin holdings, fueling intense debates between bullish investors tracking the stock's role as a levered crypto proxy and bearish traders betting on potential dilution and equity risks. Community discourse is highly polarized, with active discussions focused on the impact of upcoming dividend restructuring and the stock's persistent correlation with Bitcoin's price trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Osborne Partners Capital Management LLC Increases Stock Holdings in Thermo Fisher Scientific Inc. $TMO

Osborne Partners Capital Management LLC lifted its position in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 7.9% in the fourth quarter, according to its most recent Form 13F filing with...

Thermo Fisher Scientific Inc. $TMO Stock Holdings Decreased by Private Wealth Partners LLC

Private Wealth Partners LLC reduced its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 5.7% in the 4th quarter, according to the company in its most recent Form 13F...

<ul class="summary-bullets"><li>Dagco added 451,240 shares, making Sellas its second-largest holding at 1.01% of portfolio weight.</li><li>The stake increase comes ahead of AACR presentation of preclinical data on SLS009, Sellas’ CDK9 inhibitor targeting acute myeloid leukemia (AML).</li><li>Investor focus remains centered on the Phase 3 Regal trial of GPS, with 72 of 80 required survival events recorded as of Dec. 26, moving the study closer to topline analysis.</li></ul>Shares of Sellas Life Sciences Group, Inc. (SLS) jumped 5% in premarket trading on Monday after U.S. investment manager Dagco increased its stake by 78% ahead of a major AACR leukemia data catalyst and the closely watched Regal survival trigger.<a href="https://stocktwits.com/symbol/SLS">SLS stock</a> snapped four sessions of gains on Monday to end over 4% lower at $4.99.<h2 class="st-heading-2">Dagco Loads Up Ahead Of SLS009 AACR Data</h2>Data compiled by Quiver Quantitative showed that Dagco added 451,240 shares on Tuesday, bringing its total holdings to 1.03 million shares valued at $4.35 million as of March 31. The position now represents its second biggest holding at 1.01% of Dagco’s disclosed portfolio, placing Sellas among its healthcare bets alongside larger pharma holdings such as Merck, Thermo Fisher Scientific and Johnson &amp; Johnson.The stake increase comes just as Sellas prepares to present new preclinical findings on SLS009, its CDK9 inhibitor for acute myeloid leukemia (AML), during a poster session at AACR in San Diego on Tuesday.According to the company, lab studies showed that SLS009 triggered leukemia-cell death by increasing activity of caspase-3, a protein involved in the body’s natural cell-death process, while lowering survival signals such as MCL-1 and survivin that help cancer cells persist. The drug also showed stronger potency with repeated exposure, with early biological effects appearing within hours and becoming more pronounced over 24 hours.Notably, SLS009 remained active in AML carrying ASXL1 and TP53 mutations, which are genetic subtypes associated with treatment resistance and poorer outcomes.&nbsp;<h2 class="st-heading-2">Regal Survival Countdown In Focus</h2>While the AACR presentation represents a near-term catalyst, investor attention remains firmly centered on the company’s ongoing Phase 3 Regal trial evaluating GPS, an immunotherapy targeting the Wilms Tumor-1 antigen, as a maintenance treatment for AML patients whose disease returned but later entered remission after additional therapy.The event-driven study will begin final analysis once 80 overall-survival events are recorded. Sellas previously said 72 events had been logged as of Dec. 26, bringing the trial closer to the threshold required to initiate topline analysis.CEO Angelos Stergiou previously said that slower accumulation of survival events in oncology trials can sometimes indicate patients are living longer than expected compared with historical assumptions. Once the 80th event occurs, the company plans to proceed with database lock, statistical analysis, trial unblinding and disclosure of topline results.<h2 class="st-heading-2">How Do Retail Traders Feel About SLS?</h2>On Stocktwits, retail sentiment for SLS was ‘extremely bullish’ amid ‘extremely high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/sls_ss_png_226ba9d4c9.webp" alt="sls ss.png" width="973" height="147"><figcaption>SLS sentiment and message volume as of April 21 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/yG19/message/650823713">noted</a> Diagco’s stake and said, “It's likely clearly see the asymmetric upside with the margin of safety of no REGAL downside.”<stembedurl>https://stocktwits.com/yG19/message/650823713</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/vlucky16/message/650846855">said</a>, “Can't wait to get update on 009, since GPS has been put on hold for an 80th event that might happen from old age.”<stembedurl>https://stocktwits.com/vlucky16/message/650846855</stembedurl>SLS stock has surged over 280% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-stock-premarket-ross-gerber-brand-backlash-ai-pivot-earnings-check/cZBIOqKRICO">Tesla Stock Rises Premarket: Investor Ross Gerber Says ‘People Just Hate The Brand Now’ As AI Pivot Faces Earnings Reality Check</a>

SLS Stock Jumps Premarket: US Investor Dagco Boosts Stake By 78% Ahead Of Fresh Cancer Drug Data Reveal 

Sellas is now Dagco’s second-largest disclosed holding, putting the small-cap leukemia biotech alongside pharma giants like Merck and Johnson & Johnson.

Equity

AE Wealth Management LLC Sells 63,724 Shares of Thermo Fisher Scientific Inc. $TMO

AE Wealth Management LLC decreased its position in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 92.4% during the 4th quarter, according to its most recent filing with the SEC. The...

Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today

Unlocking Q1 Potential of Thermo Fisher (TMO): Exploring Wall Street Estimates for Key Metrics

Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zurcher Kantonalbank Zurich Cantonalbank Has $210.67 Million Holdings in Thermo Fisher Scientific Inc. $TMO

Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 54.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3...

Local Pensions Partnership Investment Ltd Cuts Holdings in Thermo Fisher Scientific Inc. $TMO

Local Pensions Partnership Investment Ltd trimmed its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 3.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 360,005 shares of the medical research company's stock after sellin...

Oak Harvest Investment Services Decreases Position in Thermo Fisher Scientific Inc. $TMO

Oak Harvest Investment Services decreased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 90.2% in the 4th quarter, according to the company in its most recent...

Thermo Fisher Scientific Inc. $TMO Shares Purchased by Cwm LLC

Cwm LLC lifted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 60.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 25,627 shares of the medical research company's stock after purchasing an additi...

Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. Thermo Fisher Scientific serves customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. The company’s global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through its brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. The company continuously increases its depth of capabilities across its broad portfolio of innovative products and services and leverages its extensive global channels to address customers’ needs. The company does this through organic investments in research and development, capacity and capabilities and through acquisitions. The company’s goal is to enable its customers to be more productive in an increasingly competitive business environment, enable them to accelerate innovation, solve their challenges and advance their important work. The company’s history roots back to the year 1956 when the business was first established. Thermo Fisher Scientific was formed in 2006 from the merger of Thermo Electron and Fisher Scientific and is headquartered in Waltham, MA.

Current Price	$527.79
Prev Close	$526.02
Open	$530.03
Dividend Yield	0.30%
50-Day Moving Average	$502.92
Beta	0.84
Avg. Volume	2.15M
PE Ratio	29.65

52-Week High	$643.99
52-Week Low	$385.46
Market Capitalization	$195.48B
EPS (Annual)	$17.74
Price to Book	3.71
Revenue Per Employee	$356,448.00

TMO
Thermo Fisher Scientific Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TMO News

TMOThermo Fisher Scientific Inc.